Anthem Biosciences Expands with New API Manufacturing Facilities

Anthem Biosciences Private limited

Anthem Biosciences is ramping up its manufacturing capacity to meet global demand for fermentation-based APIs and complex custom synthesis. Its third facility, dedicated to peptides and fermentation production, is now operational with an investment of Rs. 600 crore. A fourth large-scale unit, spread across 30 acres—larger than all previous units combined—is under development and expected to be ready in two years.

Location:  Karnataka

Estimated Value (Rs. Cr): 600

Sector: Drugs/Pharma

Project Stage: Under Implementation

Contact Details: You need to be a paid subscriber to get these details. Contacts are available in the ProjectX India 15th July 2025 PDF Edition.

. Do you want to buy this issue or our latest issue? If yes! click here

*Image used in this post if any, is for illustration only

India Projects News | Drugs/Pharma sector Project News

ProjectX India fortnightly PDF edition empowers you with new projects in India, accelerating your business with timely information on upcoming and ongoing projects, contract awards, and tenders. Discover actionable new project opportunities and access related contacts with ease. Delivered straight to your inbox every fortnight, ProjectX India keeps you ahead with the latest project insights.

Do subscribe and get 24 fortnightly issues in a year.  Click here to know more

Do you want to try out a copy of ProjectX India PDF edition?

Click here to try out an evaluation copy that covers new projects from India, ongoing projects from India, contract awards from India, and public procurement opportunities from India.


WhatsApp us at 877 927 9155 for subscriptions or advertising on this website and digital edition.